{
  "company": "CIPLA",
  "report_date": "August 7, 2020",
  "filename": "CIPLA_transcript_Aug_2020.pdf",
  "quarter": "Q1",
  "fiscal_year": "2021",
  "management_team": [
    "MR. UMANG VOHRA - MANAGING DIRECTOR &",
    "MR. KEDAR UPADHYE - GLOBAL CFO, CIPLA",
    "MR. NAVEEN BANSAL - INVESTOR RELATIONS, CIPLA",
    "UMANG VOHRA - MANAGING DIRECTOR &",
    "KEDAR UPADHYE - GLOBAL CFO, CIPLA",
    "NAVEEN BANSAL - INVESTOR RELATIONS, CIPLA"
  ],
  "moderator": "MR",
  "analysts": [
    {
      "name": "Krishnendu Saha",
      "firm": "Quantum Asset \nManagement"
    },
    {
      "name": "Prakash",
      "firm": "Axis Capital"
    },
    {
      "name": "Nithya Balasubramanian",
      "firm": "Bernstein"
    },
    {
      "name": "Sameer",
      "firm": "Morgan Stanley"
    },
    {
      "name": "Neha Manpuria",
      "firm": "JPMorgan Chase & Co"
    },
    {
      "name": "Anubhav Aggarwal",
      "firm": "Credit Suisse"
    },
    {
      "name": "Girish Bakhru",
      "firm": "Bank of America"
    },
    {
      "name": "Shyam",
      "firm": "Goldman Sachs"
    },
    {
      "name": "Nikhil Mathur",
      "firm": "Ambit Capital"
    },
    {
      "name": "Ashish Agrawal",
      "firm": "Motilal Oswal"
    },
    {
      "name": "Tarang Agrawal",
      "firm": "Old Bridge Capital"
    }
  ],
  "qa_segments": [],
  "key_financial_metrics": {
    "sales_inr_crores": "936",
    "growth_percentage": "46"
  },
  "business_highlights": [
    "partnership with Gilead for Remdesivir, we launched Cipremi in July for India.",
    "partnership with Boehringer \nIngelheim for three oral anti-diabetic products, which are SGLT2 and DPP4 inhibitors and \nextended our partnership with Roche for three oncology products, which are Trastuzumab, \nBevacizumab and Rituximab.",
    "partnerships with deals that we have signed for the emerging \nmarkets."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:50.546810",
    "source_file": "data\\cipla\\CIPLA_transcript_Aug_2020.pdf",
    "text_length": 59483,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}